Author Correction: Survodutide in adults with obesity and metabolic dysfunction-associated steatotic liver disease: SYNCHRONIZE-MASLD, a randomized, double-blind, placebo-controlled phase 3 trial

Lee M. Kaplan, Elena Startseva, Carel W. le Roux, Sean Wharton, Biykem Bozkurt, Daniel F. Mazo, Jessica von Schlippenbach, Sandra González Maldonado, Samina Ajaz Hussain, Guy W. Neff, Yaneicy Gonzalez Rojas, Charles Smith, Ramy Younes, Arun J. Sanyal, Unknown, Antonio Olveira, Juan M. Pericás, Mark Leibowitz, Douglas Denham, Kevin Korenblat, Michael Herman, Shekhar Challa, Rasha Youssef, Masi Khaja, Apinya Vutikullird, Humberto Aguilar, Naga Chalasani, James Maher, Ronald Surowitz, Cassandra Steimle, Yaneicy G. Rojas, Antonio Sanchez, Ruth E. Kavcioglu, Julio Vijil, Robert Perry, Guy Neff, Martha G. Navarro, Omer Khalid, Rizwana Mohseni, Michael Zimmerman, Julie Vu, Gregg Lucksinger, Satish Iduru, Dmitry Shuster, Bruce Segal, Paul Hellstern

Open source

DOI: 10.1038/s41591-026-04650-w
Published: 2026-08-25
Container: Nature Medicine
Publisher: Springer Science and Business Media LLC
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1038/s41591-026-04650-w,
  title = {Author Correction: Survodutide in adults with obesity and metabolic dysfunction-associated steatotic liver disease: SYNCHRONIZE-MASLD, a randomized, double-blind, placebo-controlled phase 3 trial},
  author = {Lee M. Kaplan and Elena Startseva and Carel W. le Roux and Sean Wharton and Biykem Bozkurt and Daniel F. Mazo and Jessica von Schlippenbach and Sandra González Maldonado and Samina Ajaz Hussain and Guy W. Neff and Yaneicy Gonzalez Rojas and Charles Smith and Ramy Younes and Arun J. Sanyal and Unknown and Antonio Olveira and Juan M. Pericás and Mark Leibowitz and Douglas Denham and Kevin Korenblat and Michael Herman and Shekhar Challa and Rasha Youssef and Masi Khaja and Apinya Vutikullird and Humberto Aguilar and Naga Chalasani and James Maher and Ronald Surowitz and Cassandra Steimle and Yaneicy G. Rojas and Antonio Sanchez and Ruth E. Kavcioglu and Julio Vijil and Robert Perry and Guy Neff and Martha G. Navarro and Omer Khalid and Rizwana Mohseni and Michael Zimmerman and Julie Vu and Gregg Lucksinger and Satish Iduru and Dmitry Shuster and Bruce Segal and Paul Hellstern},
  year = {2026},
  journal = {Nature Medicine},
  doi = {10.1038/s41591-026-04650-w},
  url = {https://doi.org/10.1038/s41591-026-04650-w}
}

RIS

TY  - JOUR
TI  - Author Correction: Survodutide in adults with obesity and metabolic dysfunction-associated steatotic liver disease: SYNCHRONIZE-MASLD, a randomized, double-blind, placebo-controlled phase 3 trial
AU  - Lee M. Kaplan
AU  - Elena Startseva
AU  - Carel W. le Roux
AU  - Sean Wharton
AU  - Biykem Bozkurt
AU  - Daniel F. Mazo
AU  - Jessica von Schlippenbach
AU  - Sandra González Maldonado
AU  - Samina Ajaz Hussain
AU  - Guy W. Neff
AU  - Yaneicy Gonzalez Rojas
AU  - Charles Smith
AU  - Ramy Younes
AU  - Arun J. Sanyal
AU  - Unknown
AU  - Antonio Olveira
AU  - Juan M. Pericás
AU  - Mark Leibowitz
AU  - Douglas Denham
AU  - Kevin Korenblat
AU  - Michael Herman
AU  - Shekhar Challa
AU  - Rasha Youssef
AU  - Masi Khaja
AU  - Apinya Vutikullird
AU  - Humberto Aguilar
AU  - Naga Chalasani
AU  - James Maher
AU  - Ronald Surowitz
AU  - Cassandra Steimle
AU  - Yaneicy G. Rojas
AU  - Antonio Sanchez
AU  - Ruth E. Kavcioglu
AU  - Julio Vijil
AU  - Robert Perry
AU  - Guy Neff
AU  - Martha G. Navarro
AU  - Omer Khalid
AU  - Rizwana Mohseni
AU  - Michael Zimmerman
AU  - Julie Vu
AU  - Gregg Lucksinger
AU  - Satish Iduru
AU  - Dmitry Shuster
AU  - Bruce Segal
AU  - Paul Hellstern
PY  - 2026
JO  - Nature Medicine
DO  - 10.1038/s41591-026-04650-w
UR  - https://doi.org/10.1038/s41591-026-04650-w
ER  -

APA

Kaplan, L. M., Startseva, E., Roux, C. W. L., Wharton, S., Bozkurt, B., Mazo, D. F., Schlippenbach, J. V., Maldonado, S. G., Hussain, S. A., Neff, G. W., Rojas, Y. G., Smith, C., Younes, R., Sanyal, A. J., Unknown, Olveira, A., Pericás, J. M., Leibowitz, M., Denham, D., Korenblat, K., Herman, M., Challa, S., Youssef, R., Khaja, M., Vutikullird, A., Aguilar, H., Chalasani, N., Maher, J., Surowitz, R., Steimle, C., Rojas, Y. G., Sanchez, A., Kavcioglu, R. E., Vijil, J., Perry, R., Neff, G., Navarro, M. G., Khalid, O., Mohseni, R., Zimmerman, M., Vu, J., Lucksinger, G., Iduru, S., Shuster, D., Segal, B., & Hellstern, P. (2026). Author Correction: Survodutide in adults with obesity and metabolic dysfunction-associated steatotic liver disease: SYNCHRONIZE-MASLD, a randomized, double-blind, placebo-controlled phase 3 trial. Nature Medicine. https://doi.org/10.1038/s41591-026-04650-w

Source records

crossref · retrieved 2026-09-26T00:41:35.607Z